These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35999394)

  • 1. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
    Kennedy A; Waters E; Rowshanravan B; Hinze C; Williams C; Janman D; Fox TA; Booth C; Pesenacker AM; Halliday N; Soskic B; Kaur S; Qureshi OS; Morris EC; Ikemizu S; Paluch C; Huo J; Davis SJ; Boucrot E; Walker LSK; Sansom DM
    Nat Immunol; 2022 Sep; 23(9):1365-1378. PubMed ID: 35999394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
    Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
    J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
    Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
    Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
    Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
    J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
    Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
    J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transendocytosis perspective on the CD28/CTLA-4 pathway.
    Soskic B; Qureshi OS; Hou T; Sansom DM
    Adv Immunol; 2014; 124():95-136. PubMed ID: 25175774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
    Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
    J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
    Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
    Halliday N; Williams C; Kennedy A; Waters E; Pesenacker AM; Soskic B; Hinze C; Hou TZ; Rowshanravan B; Janman D; Walker LSK; Sansom DM
    Front Immunol; 2020; 11():600000. PubMed ID: 33363541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular concentrations of Ca(2+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/CD86 interactions in CD4(+) T lymphocytes.
    Ahmed A; Mukherjee S; Nandi D
    Immunology; 2009 Mar; 126(3):363-77. PubMed ID: 18710402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics.
    van der Merwe PA; Bodian DL; Daenke S; Linsley P; Davis SJ
    J Exp Med; 1997 Feb; 185(3):393-403. PubMed ID: 9053440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
    Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
    Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.
    Steiner K; Waase I; Rau T; Dietrich M; Fleischer B; Bröker BM
    Clin Exp Immunol; 1999 Mar; 115(3):451-7. PubMed ID: 10193417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Analysis of CTLA-4-Mediated Transendocytosis by Regulatory T Cells.
    Waters E; Williams C; Kennedy A; Sansom DM
    Methods Mol Biol; 2023; 2559():171-187. PubMed ID: 36180633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.
    Soskic B; Jeffery LE; Kennedy A; Gardner DH; Hou TZ; Halliday N; Williams C; Janman D; Rowshanravan B; Hirschfield GM; Sansom DM
    Front Immunol; 2020; 11():577655. PubMed ID: 33488578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.
    Peach RJ; Bajorath J; Naemura J; Leytze G; Greene J; Aruffo A; Linsley PS
    J Biol Chem; 1995 Sep; 270(36):21181-7. PubMed ID: 7545666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.